This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mack, M. J. Search for Related Content PubMed PubMed Citation Articles by Mack, M. J. Related Collections Valvular heart disease CV surgery: valvular disease

(Circulation. 2006;114:363-364.)
© 2006 American Heart Association, Inc.

Editorial

Coronary Sinus in the Management of Functional Mitral Regurgitation

The Mother Lode or Fool’s Gold?

Michael J. Mack, MD

From Medical City Hospital and Cardiopulmonary Research Science and Technology, Dallas, Tex.

Correspondence to Michael J. Mack, Cardiopulmonary Research Science and Technology, 777 Forest Ln, Dallas, TX 75320. E-mail mjmack@earthlink.net

Key Words: Editorials • regurgitation • valvuloplasty • mitral valve

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The past 5 years have seen the introduction into the preclinical arena of myriad devices for the potential treatment of functional and ischemic mitral regurgitation by a percutaneous approach.¹ A number of the device concepts have taken advantage of the relatively easy access to the posterior annulus of the mitral valve provided by the coronary sinus. Although attractive on initial consideration as a delivery route for devices that remodel the posterior mitral annulus, a number of potential shortcomings to this approach may ultimately limit its clinical success.

Article p 377

Annular remodeling of the mitral valve for functional mitral regurgitation (FMR) has been demonstrated to have short-term and some intermediate-term efficacy in the clinical surgical setting.² The pathophysiology of FMR in patients with dilated cardiomyopathy is central regurgitation caused by failure of mitral leaflet coaptation. The causes of this malcoaptation are multifactorial and include annular dilatation and ventricular dilation, which cause apical distraction of the papillary muscles, producing tethering of the mitral leaflets. Although the whole annulus has been demonstrated to dilate in FMR, there is a disproportionate increase in the anterior-posterior or septal-lateral diameter.^3,4 The basic premise behind the surgical approach is that through the use of an undersized ring to overcorrect the dilation of the mitral annulus, both the annular dilatation and the tethering of the leaflets from apical papillary muscle displacement can be treated. The tenets for optimal surgical correction include performing the annuloplasty with a complete rather than a partial ring and firmly anchoring the ring . . . [Full Text of this Article]

This article has been cited by other articles:

				C. E. Ruiz and I. Kronzon The Wishful Thinking of Indirect Mitral Annuloplasty: Will It Ever Become a Reality? Circ Cardiovasc Interv, August 1, 2009; 2(4): 271 - 272. [Full Text] [PDF]

				J.-B. Masson and J. G. Webb Percutaneous Treatment of Mitral Regurgitation Circ Cardiovasc Interv, April 1, 2009; 2(2): 140 - 146. [Full Text] [PDF]

				P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow Evolving Concepts and Technologies in Mitral Valve Repair Circulation, February 19, 2008; 117(7): 963 - 974. [Full Text] [PDF]

				Percutaneous Mitral Annuloplasty for Functional MR Journal Watch Cardiology, October 4, 2006; 2006(1004): 5 - 5. [Full Text]